When.com Web Search

  1. Ads

    related to: new adhd meds for adults with high blood pressure and headaches

Search results

  1. Results From The WOW.Com Content Network
  2. Management of attention deficit hyperactivity disorder

    en.wikipedia.org/wiki/Management_of_attention...

    Clonidine was initially developed as a treatment for high blood pressure. Low doses in evenings and/or afternoons are sometimes used in conjunction with stimulants to help with sleep and because clonidine sometimes helps moderate impulsive and oppositional behavior and may reduce tics. [97] It may be more useful for comorbid Tourette syndrome.

  3. Guanfacine - Wikipedia

    en.wikipedia.org/wiki/Guanfacine

    Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure. [3] [10] Common side effects include sleepiness, constipation, and dry mouth. [10]

  4. What’s the best treatment for ADHD? Large new study ... - AOL

    www.aol.com/news/best-treatment-adhd-large-study...

    Stimulant medications and certain therapies are more effective in treating ADHD symptoms than placebos, a new study on more than 14,000 adults has ... a new study on more than 14,000 adults has found.

  5. List of investigational attention deficit hyperactivity ...

    en.wikipedia.org/wiki/List_of_investigational...

    This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...

  6. Serdexmethylphenidate - Wikipedia

    en.wikipedia.org/wiki/Serdexmethylphenidate

    Serdexmethylphenidate is a prodrug of dexmethylphenidate created by the pharmaceutical company KemPharm (now Zevra Therapeutics). The compound was first approved by the FDA as one of the active ingredients in Azstarys for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults in March 2021.

  7. Adults with ADHD may die up to 11 years younger, new ... - AOL

    www.aol.com/news/adults-adhd-may-die-11...

    The research, published in The British Journal of Psychiatry, examined the anonymised primary care data of 30,029 adults across the UK with diagnosed ADHD, and compared them to 300,390 adults ...